Author:
Acevedo-Canabal Agnes,Pantouli Fani,Ravichandran Akshaya,Rullo Laura,Bohn Laura M.
Reference163 articles.
1. Addiction and the laboratory. The work of the National Research Council's Committee on Drug Addiction, 1928-1939;Acker;Isis,1995
2. Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents;Altarifi;Journal of Psychopharmacology,2017
3. The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats;Austin Zamarripa;Drug and Alcohol Dependence,2018
4. Evaluating the incidence of opioid-induced respiratory depression associated with oliceridine and morphine as measured by the frequency and average cumulative duration of dosing interruption in patients treated for acute postoperative pain;Ayad;Clinical Drug Investigation,2020
5. Hot topics in opioid pharmacology: Mixed and biased opioids;Azzam;British Journal of Anaesthesia,2019